News | March 21, 2022
Lonza signs manufacturing agreement with Oasmia Pharmaceutical
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The product will be commercialized from Unichem's Ghaziabad plant
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The company is doubling its chemistry research capacity that should commission by Q2'FY22
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
Subscribe To Our Newsletter & Stay Updated
